865087-09-8 Usage
Uses
Used in Pharmaceutical Industry:
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-4-[(1E,3S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-phenyl-1-pentenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester is used as a potential pharmaceutical agent for its unique molecular structure that may offer specific binding or interaction properties with biological targets, contributing to the development of new drugs or therapeutic agents.
Used in Chemical Research:
In the field of chemical research, this compound serves as a subject for studying the synthesis of complex organic molecules, understanding their reactivity, and exploring their potential applications in various chemical processes.
Used in Material Science:
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-4-[(1E,3S)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5phenyl-1-pentenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-yl ester may also be utilized in material science for the development of new materials with unique properties, such as specific binding affinities, catalytic activity, or other characteristics that could be beneficial in various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 865087-09-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,5,0,8 and 7 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 865087-09:
(8*8)+(7*6)+(6*5)+(5*0)+(4*8)+(3*7)+(2*0)+(1*9)=198
198 % 10 = 8
So 865087-09-8 is a valid CAS Registry Number.
865087-09-8Relevant articles and documents
Bimatoprost crystalline form I
-
Page/Page column 11-12, (2009/07/10)
The invention provides a novel polymorphic form I of crystalline bimatoprost, method for preparation thereof and new crystalline intermediates in the preparation. This form I of crystalline bimatoprost is used in purification of crude bimatoprost and in storage of bimatoprost as active pharmaceutical intermediate. Use of the physical form of bimatoprost in the manufacture of a medicament is also disclosed.